New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
11:02 EDTBMYBristol-Myers enters development pact with Leica Biosystem
Leica Biosystems announced an agreement with Bristol-Myers Squibb to collaborate on developing companion diagnostics on the Leica BOND system for use as an aid in selecting patients for treatment with certain pharmaceuticals developed, or to be developed, by Bristol-Myers Squibb. Other terms of the agreement were not disclosed.
News For BMY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 22, 2014
17:23 EDTBMYBristol-Myers confirms FDA approval of Opdivo
Bristol-Myers Squibb Company announced that the FDA approved Opdivo injection, for intravenous use. Opdivo is a human programmed death receptor-1 blocking antibody indicated for the treatment of patients with unresectable or metastatic melanoma and disease progression following Yervoy and, if BRAF V600 mutation positive, a BRAF inhibitor. This indication is approved under accelerated approval based on tumor response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in the confirmatory trials. The company expects to begin shipping Opdivo within one to two weeks of today’s approval.
15:12 EDTBMYBristol-Myers confirms FDA approval of Opdivo
Subscribe for More Information
14:34 EDTBMYBristol-Myers prices Opdivo at $12.5K per month, CNBC report
Subscribe for More Information
14:28 EDTBMYFDA grants accelerated approval to Bristol-Myers melanoma drug
Subscribe for More Information
December 16, 2014
08:47 EDTBMYHemispherx Ampligen provides anti-tumor activity
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use